Evidence map›Paper›PMID 20019862›Full record

ArticleDeutsches Arzteblatt international2009

Influenza--insights from mathematical modelling.

Rafael Mikolajczyk, Ralf Krumkamp, Reinhard Bornemann, Amena Ahmad, Markus Schwehm, Hans-Peter Duerr

Abstract read
In one paragraph

Article in Deutsches Arzteblatt international, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Mathematical Analysis of Influenza A Dynamics in the Emergence of Drug Resistance.Computational and mathematical methods in medicine · 2018
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Rafael MikolajczykFakultät für Gesundheitswissenschaften, Universität Bielefeld, Bielefeld. mikolajczyk@uni-bielefeld.de
Ralf Krumkamp
Reinhard Bornemann
Amena Ahmad
Markus Schwehm
Hans-Peter Duerr

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhen the first cases of a new infectious disease appear, questions arise about the further course of the epidemic and about the appropriate interventions to be taken to protect individuals and the public as a whole. Mathematical models can help answer these questions. In this article, the authors describe basic concepts in the mathematical modelling of infectious diseases, illustrate their use with a simple example, and present the results of influenza models.

methodDescription of the mathematical modelling of infectious diseases and selective review of the literature.

resultsThe two fundamental concepts of mathematical modelling of infectious diseases-the basic reproduction number and the generation time-allow a better understanding of the course of an epidemic. Modelling studies based on past influenza epidemics suggest that the rise of the epidemic curve can be slowed at the beginning of the epidemic by isolating ill persons and giving prophylactic medications to their contacts. Later on in the course of the epidemic, restricting the number of contacts (e.g., by closing schools) may mitigate the epidemic but will only have a limited effect on the total number of persons who contract the disease.

conclusionMathematical modelling is a valuable tool for understanding the dynamics of an epidemic and for planning and evaluating interventions.

Indexed as

Models, BiologicalPopulation SurveillanceProportional Hazards ModelsComputer SimulationDisease OutbreaksGermanyHumansIncidenceInfluenza, HumanRisk AssessmentRisk Factorsdisease courseepidemicinfection controlinfluenzaprevention

Identifiers

PMID20019862
PMCPMC2795334

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.